Here's Merck's $3.3 Billion Insurance Against Summit's Advance
Mirum Pharmaceuticals (MIRM) saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 89 to 93. ↑ X NOW PLAYING How To Find The Best IPO Stocks IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) …